SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 94 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $445,000 | +15.9% | 15,600 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $384,000 | -53.7% | 15,600 | +6.1% | 0.00% | -33.3% |
| Q1 2022 | $829,000 | -9.0% | 14,700 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $911,000 | -2.3% | 14,700 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $932,000 | -24.6% | 14,700 | -2.0% | 0.00% | 0.0% |
| Q2 2021 | $1,236,000 | +22.7% | 15,000 | +9.5% | 0.00% | 0.0% |
| Q1 2021 | $1,007,000 | +1.4% | 13,700 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $993,000 | +27.1% | 13,700 | -16.5% | 0.00% | +33.3% |
| Q3 2020 | $781,000 | +245.6% | 16,400 | +203.7% | 0.00% | +200.0% |
| Q2 2020 | $226,000 | +213.9% | 5,400 | +100.0% | 0.00% | – |
| Q1 2020 | $72,000 | -30.1% | 2,700 | 0.0% | 0.00% | – |
| Q4 2019 | $103,000 | – | 2,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |